The COVID-19 vaccine confers protection against the development of post-COVID-19 conditions, particularly during the Delta and Omicron eras.

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

Shipping giant Purolator has lost in B.C. Supreme Court after it tried to challenge an arbitrator's decision to compensate ...

A Tennessee federal court has upheld a jury’s verdict in favor of former BlueCross BlueShield of Tennessee (BCBST) employee ...

A newly developed vaccine against a group of viruses including SARS-CoV-2 is producing promising results in mice, part of the ...

It's flu season right now, and the U.S. is in the midst of a wave that's straining hospitals. But not all influenza is the ...

The Illinois Department of Public Health (IDPH) reported respiratory illnesses have increased and the illness level is now at ...

Former health minister Khairy Jamaluddin testified in the Kuala Lumpur High Court today that his defamation suit seeks to inform the public against the lies and falsehood on Covid-19 vaccination. The ...

Trump may have distanced himself from Project 2025 on the campaign trail, but many of his policies align with those included ...

Health experts are seeing signs of a much smaller wave of U.S. COVID-19 cases this winter than in previous years, which could ...

President Donald Trump has unilaterally decided for 340 million Americans that we no longer need to be a part of the World Health Organization. Listen, he knows more about science than all the ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...